Optimal Analgesia in Acute Gastroenteritis

Phase 3

Terminated

• Conditions: Gastroenteritis
• Interventions: Drug: Papaverine; Drug: Dipyrone

• Registration Number: NCT02711241
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

The purpose of this study is to find out an optimal way of analgesia in case of acute infectious gastroenteritis the investigators are going to compare two medicines that are used on everyday basis (without being ever before subject to scientifical study): Dipyrone and papaverine The study is done in the Emergency Department setting. Thus, only first 6 hours of treatment is included in study

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Study First Submitted: 2011-03-01
• Status Verified: 2016-03
• Study First Submitted QC: 2016-03-13
• Last Update Submitted: 2016-03-13
• Study First Posted: 2016-03-17
• Last Update Posted: 2016-03-17

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• acute gastroenteritis
• VAS scale of pain perception at least 4

Exclusion Criteria

• pregnancy
• allergy to any one of study preparations
• blood pressure less than 85 on admission
• surgical condition (acute abdomen) suspected or diagnosed

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Papaverine	Papaverine	-
Dipyrone	Dipyrone	-

Primary Outcome Measures

Name	Time	Method
Change in pain assessment (VAS) as opposed the pain assessment on admission	30 min, 1 hour, 2 hours, on discharge (up to 24 hours)

Secondary Outcome Measures

Name	Time	Method
Need for second analgesic medicine	24 hours

Trial Locations

Locations (1)

Hadssah Medical Organisation; 🇮🇱 Jerusalem, Israel